Kenji Tsuchihashi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Systematic Review

Epidermal Growth Factor Receptor

Top Venues

International journal of clinical oncology

JCO precision oncology

Japanese journal of clinical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, Hirofumi Ohmura, Tomoyasu Yoshihiro, Kenro Tanoue, Satoshi Nishiyori, Eiji Iwama, Takahiro Maeda, Koichi Akashi, Eishi Baba
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO precision oncology 8 (2024)
Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, Hirofumi Ohmura, Tomoyasu Yoshihiro, Kenro Tanoue, Satoshi Nishiyori, Eiji Iwama, Takahiro Maeda, Koichi Akashi, Eishi Baba
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO precision oncology 8 (2024)
Kenji Tsuchihashi, Eishi Baba
Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy. Japanese journal of clinical oncology 54 (7) (2024)
Mamoru Ito, Yuta Okumura, Kenta Nio, Eishi Baba, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Kenji Tsuchihashi
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology. International journal of clinical oncology (2024)
Mamoru Ito, Yuta Okumura, Kenta Nio, Eishi Baba, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Kenji Tsuchihashi
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology. International journal of clinical oncology 29 (6) (2024)
Mamoru Ito, Yuta Okumura, Kenta Nio, Eishi Baba, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Kenji Tsuchihashi
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology. International journal of clinical oncology 29 (6) (2024)
Kenji Tsuchihashi, Eishi Baba
Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy. Japanese journal of clinical oncology (2024)
Hitomi Sumiyoshi Okuma, Keisuke Watanabe, Kenji Tsuchihashi, Ryunosuke Machida, Ryo Sadachi, Akihiro Hirakawa, Hiroshi Ariyama, Masashi Kanai, Masahisa Kamikura, Kenta Anjo, Akari Hiramitsu, Shigeki Sekine, Natsuko Okita, Hiroyuki Mano, Hiroyoshi Nishikawa, Kenichi Nakamura, Kan Yonemori
Phase 2 trial of nivolumab in metastatic rare cancer with dMMR or MSI-H and relation with immune phenotypic analysis (the ROCK trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)